Phase II Trial of Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens (AV-GBM-1) as an Adjunctive Therapy Following Primary Surgery Plus Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma
Investigator(s):
Daniela Bota, M.D., Ph.D.;
Organization:
UCI
NCT Number:
Disease Name:
Glioblastoma
Disease Category:
Trial Phases:
Phase 2
Trial Status:
Active, Not Recruiting
Trial Contact:
Active trials at UCI: http://clinic.stemcell.uci.edu/search-clinical-trials.asp
Contact for all open studies at UCI:
(949) 824-3990
stemcell@uci.edu